Clinical relevance of molecular markers in lung cancer

Author： Iyengar P.   Tsao M.-S.  

Publisher： Elsevier

ISSN： 0960-7404

Source： Surgical Oncology, Vol.11, Iss.4, 2002-12, pp. : 167-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular markers in colorectal cancer: clinical relevance in stage II colon cancer

By Santos Cristina   Vilar Eduardo   Capella Gabriel   Salazar Ramon  

Colorectal Cancer, Vol. 2, Iss. 3, 2013-06 ,pp. : 243-263

Future Medicine

Access to resources Recommend Favorite

Molecular and clinical risk markers in colon cancer trials

By Hill M.J.  

European Journal of Cancer, Vol. 36, Iss. 10, 2000-06 ,pp. : 1288-1291

Elsevier

Access to resources Recommend Favorite

The clinical relevance of urine-based markers for diagnosis of bladder cancer

By Eissa Sanaa  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 513-518

Humana Press, Inc

Access to resources Recommend Favorite

The clinical importance of bone metabolic markers in detecting bone metastasis of lung cancer

By Bayrak Suna  

International Journal of Clinical Oncology, Vol. 17, Iss. 2, 2012-04 ,pp. : 112-118

Springer Publishing Company

Access to resources Recommend Favorite

Circulating molecular markers in pancreatic cancer: ready for clinical use?

By Gall Tamara MH   Frampton Adam E   Krell Jonathan   Castellano Leandro   Jiao Long R  

Future Oncology, Vol. 9, Iss. 2, 2013-02 ,pp. : 141-144

Future Medicine

Access to resources Recommend Favorite